Cargando…

Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis

INTRODUCTION: Multiple agents are approved in the adjuvant setting of completely resected high-risk (stages IIC–IV) malignant melanoma. Subgroups may benefit differently depending on the agent used. We performed a systematic review and meta-analysis to evaluate the efficiency and tolerability of ava...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christofyllakis, Konstantinos, Pföhler, Claudia, Bewarder, Moritz, Müller, Cornelia S. L., Thurner, Lorenz, Rixecker, Torben, Vogt, Thomas, Stilgenbauer, Stephan, Yordanova, Krista, Kaddu-Mulindwa, Dominic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930562/ https://www.ncbi.nlm.nih.gov/pubmed/33680957 http://dx.doi.org/10.3389/fonc.2020.637161

Ejemplares similares

Current Treatment Options in CLL
por: Bewarder, Moritz, et al.
Publicado: (2021)

Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2022)

Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
por: Lesan, Vadim, et al.
Publicado: (2021)

Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies
por: Christofyllakis, Konstantinos, et al.
Publicado: (2023)

Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
por: Kos, Igor, et al.
Publicado: (2021)

Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021)

IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study
por: Kaddu‐Mulindwa, Dominic, et al.
Publicado: (2021)

Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma
por: Bewarder, Moritz, et al.
Publicado: (2020)

Advances in Lymphoma Molecular Diagnostics
por: Kos, Igor Age, et al.
Publicado: (2021)

Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
por: Bewarder, Moritz, et al.
Publicado: (2020)

PB2104: DOSE-DENSE CHEMOTHERAPY WITH R-CHOP-14 IN OLDER ADULTS AGED ≥80 YEARS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Christofyllakis, K., et al.
Publicado: (2022)

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
por: Kos, Igor, et al.
Publicado: (2020)

The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
por: Bewarder, Moritz, et al.
Publicado: (2021)

Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP
por: Bewarder, Moritz, et al.
Publicado: (2023)

Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
por: Kiefer, Maximilian, et al.
Publicado: (2022)

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021)

Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2022)

Role of Specific B-Cell Receptor Antigens in Lymphomagenesis
por: Thurner, Lorenz, et al.
Publicado: (2020)

Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition
por: Thurner, Lorenz, et al.
Publicado: (2020)

The riddle of lymphoma BCR-antigenes
por: Thurner, Lorenz, et al.
Publicado: (2018)

Etanercept leads to a rapid recovery of a Dabrafenib‐/Trametinib‐associated toxic epidermal necrolysis‐like severe skin reaction
por: Yordanova, Krista, et al.
Publicado: (2022)

Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature
por: Kos, Igor, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States
por: Zhang, Shujing, et al.
Publicado: (2023)

Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma
por: Thurner, Lorenz, et al.
Publicado: (2020)

Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins
por: Lee, Jooyoung, et al.
Publicado: (2018)

Autoantibodies against SUMO1-DHX35 in long-COVID
por: Thurner, Lorenz, et al.
Publicado: (2022)

Unilateral transnasal endoscopic approach to frontal sinuses: Draf IIc
por: Al Komser, Mohammed K., et al.
Publicado: (2013)

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4
por: Li, Xuzichao, et al.
Publicado: (2023)

A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update
por: Biswas, S, et al.
Publicado: (2008)

Transitions between the steps of forward and reverse splicing of group IIC introns
por: Smathers, Claire M., et al.
Publicado: (2020)

Case Report: Hemophagocytic Lymphocytosis in a Patient With Glutaric Aciduria Type IIC
por: Huang, Lingtong, et al.
Publicado: (2022)

Survey of Brucella infection and malaria among Abattoir workers in Kampala and Mbarara Districts, Uganda
por: Nabukenya, Immaculate, et al.
Publicado: (2013)

Activation of actin polymerization by phosphatidic acid derived from phosphatidylcholine in IIC9 fibroblasts
Publicado: (1993)

Diversity and strength of internal outward-oriented promoters in group IIC-attC introns
por: Léon, Grégory, et al.
Publicado: (2010)

Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
por: Brokāne, Linda, et al.
Publicado: (2019)

Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc
por: Zalem, Dani, et al.
Publicado: (2021)

A redox switch regulates the assembly and anti-CRISPR activity of AcrIIC1
por: Zhao, Yanan, et al.
Publicado: (2022)

Rare portal hypertension caused by Abernethy malformation (Type IIC): A case report
por: Yao, Xin, et al.
Publicado: (2023)

Expression of nonmuscle myosin IIC is regulated by non-canonical binding activity of miRNAs
por: Banerjee, Kumarjeet, et al.
Publicado: (2023)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
por: Hartmann, Sylvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a94loimlm9r2n2drj40ode7ojt